Search

To mark National Cancer Prevention Month this February, MSK shared several tips to help reduce the risk of developing cancer.

… Tuesday, February 16, 2021 Summary Advice supports mission of National Cancer Prevention Month, as COVID-19 pandemic leads to an alarming drop in cancer screenings, diagnoses and treatment nationwide. To mark National Cancer Prevention Month this February, Memorial Sloan Kettering Cancer Center (MSK)

FoundationOne Heme was developed using technology, methods and computational algorithms developed by Foundation Medicine, combined with Memorial Sloan Kettering’s deep and vast expertise in clinical and laboratory research into hematologic malignancies.

… Saturday, December 7, 2013 Foundation Medicine announced today the launch of its second clinical product, FoundationOne™ Heme, a fully informative genomic profile for hematologic cancers (leukemia, lymphoma and myeloma), as well as many sarcomas and pediatric cancers. The test has been developed in collaboration

Memorial Sloan Kettering Cancer Center (MSKCC) opened a new state-of-the-art outpatient cancer treatment facility in Basking Ridge, New Jersey, today. The new 85,000-square-foot facility incorporates the latest concepts in therapeutic design and offers the most advanced cancer care services.

… Tuesday, September 5, 2006 Memorial Sloan Kettering Cancer Center (MSKCC) opened a new state-of-the-art outpatient cancer treatment facility in Basking Ridge, New Jersey , today. The new 85,000-square-foot facility incorporates the latest concepts in therapeutic design and offers the most advanced cancer

Learn how the Lisa and Scott Stuart Center for Adolescent and Young Adult Cancers at Memorial Sloan Kettering is transforming the experience, care, and outcomes of teens and young adults with cancer.

… Monday, September 27, 2021 Imagine: Just as you’re finding your footing in the real world — graduating school, starting a new job, getting married, building a family — you’re diagnosed with cancer. It sounds implausible, but it happens to 90,000 teens and young adults in America each year. “Nobody is

Image-guided interventions are revolutionizing cancer diagnosis and treatment. MSKCC's new Center for Image-Guided Intervention (CIGI), which opened in June, offers cancer patients the most advanced, minimally invasive diagnostic and treatment options in a unique multidisciplinary setting designed to foster rapid innovations in cancer care.

… Wednesday, July 7, 2010 Image-guided interventions are revolutionizing cancer diagnosis and treatment. MSKCC’s new Center for Image-Guided Intervention (CIGI), which opened in June, offers cancer patients the most advanced, minimally invasive diagnostic and treatment options in a unique multidisciplinary

MSK ranked #17 out of 500 companies and is the second highest ranked hospital.

… Thursday, April 29, 2021 Forbes has named Memorial Sloan Kettering Cancer Center one of America’s Best Employers for Diversity , ranking the organization #17 out of 500 companies, and the second highest ranked hospital. It’s MSK’s second year on the fourth annual list. “At MSK, we’re committed to ensuring

A new study by researchers at Memorial Sloan Kettering Cancer Center reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse.

… Thursday, July 2, 2009 A new study by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse. The study will be published

A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed.

… Thursday, April 9, 2009 A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed. The study, led by researchers at Memorial Sloan Kettering

By uncovering the root cause of cytokine release syndrome, MSK researchers have found a way to stop it.

… Monday, May 28, 2018 Summary Researchers at the Sloan Kettering Institute have identified the cause of a serious immunotherapy side effect as well as ways to stop or prevent it. The study was done in mice but the approach will soon be tested in people. CAR T cell therapy CAR T cell therapy is helping

Research in blood stem cells has revealed new information about how these cells decide what to become when they divide.

… Tuesday, August 13, 2019 Summary By knocking out an important enzyme in blood stem cells, Sloan Kettering Institute investigators have found new details about how these cells decide what to become when they divide. Stem cells are defined by their ability to differentiate into other, more specialized